H. Ledermann
Impact in
Papers in
-
- Blood Pressure and Hypertension Studies 2
- Lipid metabolism and disorders 2
-
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Wolfgang Köpcke (1 shared paper)Hans Lithell (2 shared papers)B. Vessby (1 shared paper)Bengt OH Vessby (1 shared paper)Inga‐Britt Gustafsson (1 shared paper)Kristoffer Hellsing (1 shared paper)Jonas Boberg (1 shared paper)Ann‐Margret Östlund‐Lindqvist (1 shared paper)
- Journals
- Diabetes (2 papers)Atherosclerosis (2 papers)The Lancet (1 paper)British Journal of Clinical Pharmacology (1 paper)European Journal of Clinical Investigation (1 paper)
- Partner nations
- SwedenUnited KingdomGermany
In The Last Decade
H. Ledermann
18 papers receiving 552 citations
Peers
Comparison fields: 5 of 60
- Genetics 205
- Surgery 271
- Neurology 53
- Cardiology and Cardiovascular Medicine 90
- Clinical Biochemistry 18
Countries citing papers authored by H. Ledermann
This map shows the geographic impact of H. Ledermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Ledermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Ledermann more than expected).
Fields of papers citing papers by H. Ledermann
This network shows the impact of papers produced by H. Ledermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Ledermann. The network helps show where H. Ledermann may publish in the future.
Co-authors
The 25 scholars most cited alongside H. Ledermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 139 | |
| 2 | 1997 | 113 | |
| 3 | 1995 | 80 | |
| 4 | 1980 | 75 | |
| 5 | 1995 | 48 | |
| 6 | 1982 | 36 | |
| 7 | 1997 | 31 | |
| 8 | 2002 | 24 | |
| 9 | 1977 | 17 | |
| 10 | 1981 | 15 | |
| 11 | 1986 | 14 | |
| 12 | 1981 | 12 | |
| 13 | 1977 | 8 | |
| 14 | Variability in the pharmacokinetics of atenolol and metoprolol. | 1985 | 7 |
| 15 | 1982 | 6 | |
| 16 | [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes]. | 1994 | 4 |
| 17 | 1981 | 2 | |
| 18 | 2008 | 1 |
About H. Ledermann
H. Ledermann is a scholar working on Cardiology and Cardiovascular Medicine, Pharmacology, Surgery, Genetics and Gastroenterology, having authored 18 papers that have together received 632 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (4 papers), Diabetes and associated disorders (4 papers), Pharmacogenetics and Drug Metabolism (3 papers), Blood Pressure and Hypertension Studies (2 papers), Lipid metabolism and disorders (2 papers), Pancreatic function and diabetes (2 papers), Sleep and related disorders (1 paper) and Drug Solubulity and Delivery Systems (1 paper). The work is most often cited by research in Genetics (205 citations), Surgery (271 citations), Neurology (53 citations), Cardiology and Cardiovascular Medicine (90 citations) and Clinical Biochemistry (18 citations). H. Ledermann has collaborated with scholars based in Sweden, United Kingdom and Germany. Frequent co-authors include Wolfgang Köpcke, Hans Lithell, B. Vessby, Bengt OH Vessby, Inga‐Britt Gustafsson, Kristoffer Hellsing, Jonas Boberg, Ann‐Margret Östlund‐Lindqvist, Kazuya Yamagata and Graeme I. Bell. Their work appears in journals such as Diabetes, Atherosclerosis, The Lancet, British Journal of Clinical Pharmacology and European Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.